| Plotted Points Statistics |
| 1-NAPHTHOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 7 | 52% | 15% | 56% | 17% |
| >= Reporting Level | 64 | 82% | 38% | 72% | 33% |
| Total | 71 | 79% | 38% | 67% | 34% |
| Sample Statistics |
| 1-NAPHTHOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 71 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| 1RS CIS-PERMETHRIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 68% | 16% | 69% | 17% |
| Total | 68 | 68% | 16% | 69% | 17% |
| Sample Statistics |
| 1RS CIS-PERMETHRIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| 2,6-DIETHYLANILINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 71 | 98% | 23% | 98% | 15% |
| Total | 71 | 98% | 23% | 98% | 15% |
| Sample Statistics |
| 2,6-DIETHYLANILINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 97% | Spiked |
| Estimated Values | 6 | 8% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 73 | . | |
| False Negatives | 2 | 3% | 2 out of 73 |
| Not Spiked | 95 | . | |
| False Positives | 0 | 0% | 0 out of 95 |
| BQS OBSP Determination: |
| 2-CHLORO-2,6-DIETHYLACETANILIDE |
| SCHEDULE: 2033 , TESTIDCODE: 61618GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| 2-CHLORO-2,6-DIETHYLACETANILIDE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 45 | 104% | 14% | 105% | 12% |
| Total | 45 | 104% | 14% | 105% | 12% |
| Sample Statistics |
| 2-CHLORO-2,6-DIETHYLACETANILIDE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 45 | 100% | Spiked |
| Estimated Values | 1 | 2% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 45 | . | |
| False Negatives | 0 | 0% | 0 out of 45 |
| Not Spiked | 123 | . | |
| False Positives | 1 | 1% | 1 out of 123 |
| BQS OBSP Determination: |
| 2-ETHYL-6-METHYLANILINE |
| SCHEDULE: 2033 , TESTIDCODE: 61620GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| 2-ETHYL-6-METHYLANILINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 50 | 89% | 24% | 92% | 13% |
| Total | 50 | 89% | 24% | 92% | 13% |
| Sample Statistics |
| 2-ETHYL-6-METHYLANILINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 50 | 98% | Spiked |
| Estimated Values | 50 | 98% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 51 | . | |
| False Negatives | 1 | 2% | 1 out of 51 |
| Not Spiked | 110 | . | |
| False Positives | 0 | 0% | 0 out of 110 |
| Plotted Points Statistics |
| 3,4-DICHLOROANILINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 81% | 9% | 82% | 10% |
| Total | 68 | 81% | 9% | 82% | 10% |
| Sample Statistics |
| 3,4-DICHLOROANILINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 99% | Spiked |
| Estimated Values | 68 | 99% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| 3,5-DICHLOROANILINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 73 | 92% | 9% | 93% | 6% |
| Total | 73 | 92% | 9% | 93% | 6% |
| Sample Statistics |
| 3,5-DICHLOROANILINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 73 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 73 | . | |
| False Negatives | 0 | 0% | 0 out of 73 |
| Not Spiked | 95 | . | |
| False Positives | 0 | 0% | 0 out of 95 |
| BQS OBSP Determination: |
| 4-CHLORO-2-METHYLPHENOL |
| SCHEDULE: 2033 , TESTIDCODE: 61633GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| 4-CHLORO-2-METHYLPHENOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 69% | 11% | 69% | 11% |
| Total | 69 | 69% | 11% | 69% | 11% |
| Sample Statistics |
| 4-CHLORO-2-METHYLPHENOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 69 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| ACETOCHLOR |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 94% | 16% | 95% | 18% |
| Total | 68 | 94% | 16% | 95% | 18% |
| Sample Statistics |
| ACETOCHLOR |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 1 | 1% | 1 out of 100 |
| Plotted Points Statistics |
| ALACHLOR |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 96% | 16% | 93% | 17% |
| Total | 70 | 96% | 16% | 93% | 17% |
| Sample Statistics |
| ALACHLOR |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 0 | 0% | 0 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 0 | 0% | 0 out of 98 |
| BQS OBSP Determination: |
| ALPHA-ENDOSULFAN (ENDOSULFAN I) |
| SCHEDULE: 2033 , TESTIDCODE: 34362GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| ALPHA-ENDOSULFAN (ENDOSULFAN I) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 90% | 15% | 87% | 12% |
| Total | 69 | 90% | 15% | 87% | 12% |
| Sample Statistics |
| ALPHA-ENDOSULFAN (ENDOSULFAN I) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| ATRAZINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 73 | 98% | 13% | 99% | 12% |
| Total | 73 | 98% | 13% | 99% | 12% |
| Sample Statistics |
| ATRAZINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 73 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 73 | . | |
| False Negatives | 0 | 0% | 0 out of 73 |
| Not Spiked | 95 | . | |
| False Positives | 0 | 0% | 0 out of 95 |
| Plotted Points Statistics |
| AZINPHOS-METHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 12 | 93% | 22% | 93% | 23% |
| >= Reporting Level | 59 | 79% | 19% | 80% | 20% |
| Total | 71 | 82% | 20% | 82% | 18% |
| Sample Statistics |
| AZINPHOS-METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 71 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| AZINPHOS-METHYL-OXON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 81% | 46% | 82% | 68% |
| >= Reporting Level | 42 | 71% | 25% | 66% | 16% |
| Total | 45 | 71% | 26% | 66% | 17% |
| Sample Statistics |
| AZINPHOS-METHYL-OXON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 45 | 88% | Spiked |
| Estimated Values | 45 | 88% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 51 | . | |
| False Negatives | 5 | 10% | 5 out of 51 |
| Not Spiked | 117 | . | |
| False Positives | 1 | 1% | 1 out of 117 |
| Plotted Points Statistics |
| BENFLURALIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 82% | 13% | 82% | 11% |
| Total | 68 | 82% | 13% | 82% | 11% |
| Sample Statistics |
| BENFLURALIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| CARBARYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 6 | 110% | 23% | 109% | 23% |
| >= Reporting Level | 65 | 88% | 17% | 89% | 17% |
| Total | 71 | 90% | 19% | 90% | 17% |
| Sample Statistics |
| CARBARYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 71 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| CARBOFURAN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 133% | 15% | 138% | 13% |
| >= Reporting Level | 67 | 102% | 16% | 102% | 16% |
| Total | 71 | 103% | 18% | 106% | 16% |
| Sample Statistics |
| CARBOFURAN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 71 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| CHLORPYRIFOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 71 | 84% | 13% | 84% | 12% |
| Total | 71 | 84% | 13% | 84% | 12% |
| Sample Statistics |
| CHLORPYRIFOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| BQS OBSP Determination: |
| CHLORPYRIFOS, OXYGEN ANALOG |
| SCHEDULE: 2033 , TESTIDCODE: 61636GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| CHLORPYRIFOS, OXYGEN ANALOG |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 9 | 74% | 20% | 72% | 16% |
| >= Reporting Level | 38 | 48% | 28% | 39% | 33% |
| Total | 47 | 53% | 28% | 53% | 34% |
| Sample Statistics |
| CHLORPYRIFOS, OXYGEN ANALOG |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 47 | 66% | Spiked |
| Estimated Values | 47 | 66% | Spiked |
| Deleted Values | 2 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 23 | 32% | 23 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 95 |
| Plotted Points Statistics |
| CIS-PROPICONAZOLE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 179% | . | 179% | 0% |
| >= Reporting Level | 36 | 54% | 44% | 37% | 18% |
| Total | 37 | 57% | 48% | 37% | 18% |
| Sample Statistics |
| CIS-PROPICONAZOLE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 37 | 100% | Spiked |
| Estimated Values | 37 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 37 | . | |
| False Negatives | 0 | 0% | 0 out of 37 |
| Not Spiked | 131 | . | |
| False Positives | 0 | 0% | 0 out of 131 |
| Plotted Points Statistics |
| CYANAZINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 100% | 19% | 98% | 16% |
| Total | 70 | 100% | 19% | 98% | 16% |
| Sample Statistics |
| CYANAZINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 99% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 1 | 1% | 1 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| CYFLUTHRIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 51 | 63% | 28% | 61% | 24% |
| Total | 51 | 63% | 28% | 61% | 24% |
| Sample Statistics |
| CYFLUTHRIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 51 | 96% | Spiked |
| Estimated Values | 51 | 96% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 53 | . | |
| False Negatives | 2 | 4% | 2 out of 53 |
| Not Spiked | 102 | . | |
| False Positives | 1 | 1% | 1 out of 102 |
| Plotted Points Statistics |
| CYHALOTHRIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 49% | 21% | 51% | 21% |
| Total | 68 | 49% | 21% | 51% | 21% |
| Sample Statistics |
| CYHALOTHRIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 97% | Spiked |
| Estimated Values | 68 | 97% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 2 | 3% | 2 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 0 | 0% | 0 out of 98 |
| Plotted Points Statistics |
| CYPERMETHRIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 71 | 66% | 18% | 61% | 17% |
| Total | 71 | 66% | 18% | 61% | 17% |
| Sample Statistics |
| CYPERMETHRIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 71 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| Plotted Points Statistics |
| DACTHAL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 101% | 13% | 100% | 13% |
| Total | 69 | 101% | 13% | 100% | 13% |
| Sample Statistics |
| DACTHAL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| BQS OBSP Determination: |
| DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
| SCHEDULE: 2033 , TESTIDCODE: 04040GCM35 |
| Open Data Set |
| Plotted Points Statistics |
| DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 88% | 31% | 85% | 36% |
| Total | 70 | 88% | 31% | 85% | 36% |
| Sample Statistics |
| DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 100% | Spiked |
| Estimated Values | 70 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 0 | 0% | 0 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 1 | 1% | 1 out of 98 |
| Plotted Points Statistics |
| DESULFINYLFIPRONIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 38 | 85% | 17% | 82% | 19% |
| Total | 38 | 85% | 17% | 82% | 19% |
| Sample Statistics |
| DESULFINYLFIPRONIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 38 | 100% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 38 | . | |
| False Negatives | 0 | 0% | 0 out of 38 |
| Not Spiked | 130 | . | |
| False Positives | 1 | 1% | 1 out of 130 |
| BQS OBSP Determination: |
| DESULFINYLFIPRONIL AMIDE |
| SCHEDULE: 2033 , TESTIDCODE: 62169GCM29 |
| Open Data Set |
| Plotted Points Statistics |
| DESULFINYLFIPRONIL AMIDE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 144% | . | 144% | 0% |
| >= Reporting Level | 7 | 88% | 28% | 73% | 30% |
| Total | 8 | 95% | 32% | 87% | 37% |
| Sample Statistics |
| DESULFINYLFIPRONIL AMIDE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 8 | 100% | Spiked |
| Estimated Values | 8 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 8 | . | |
| False Negatives | 0 | 0% | 0 out of 8 |
| Not Spiked | 160 | . | |
| False Positives | 0 | 0% | 0 out of 160 |
| Plotted Points Statistics |
| DIAZINON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 100% | 11% | 100% | 12% |
| Total | 69 | 100% | 11% | 100% | 12% |
| Sample Statistics |
| DIAZINON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| BQS OBSP Determination: |
| DIAZINON, OXYGEN ANALOG |
| SCHEDULE: 2033 , TESTIDCODE: 61638GCM14 |
| Open Data Set |
| Plotted Points Statistics |
| DIAZINON, OXYGEN ANALOG |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 61 | 91% | 24% | 84% | 20% |
| Total | 61 | 91% | 24% | 84% | 20% |
| Sample Statistics |
| DIAZINON, OXYGEN ANALOG |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 61 | 95% | Spiked |
| Estimated Values | 9 | 14% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 64 | . | |
| False Negatives | 2 | 3% | 2 out of 64 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| BQS OBSP Determination: |
| DICHLOROVOS (DICHLORVOS) |
| SCHEDULE: 2033 , TESTIDCODE: 38775GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| DICHLOROVOS (DICHLORVOS) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 16 | 75% | 20% | 72% | 17% |
| >= Reporting Level | 54 | 57% | 26% | 60% | 22% |
| Total | 70 | 61% | 25% | 66% | 22% |
| Sample Statistics |
| DICHLOROVOS (DICHLORVOS) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 99% | Spiked |
| Estimated Values | 70 | 99% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 1 | 1% | 1 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| Plotted Points Statistics |
| DICROTOPHOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 6 | 44% | 6% | 44% | 4% |
| >= Reporting Level | 65 | 30% | 10% | 29% | 11% |
| Total | 71 | 31% | 11% | 29% | 13% |
| Sample Statistics |
| DICROTOPHOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 71 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| Plotted Points Statistics |
| DIELDRIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 74 | 92% | 16% | 91% | 15% |
| Total | 74 | 92% | 16% | 91% | 15% |
| Sample Statistics |
| DIELDRIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 74 | 100% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 0 | 0% | 0 out of 74 |
| Not Spiked | 94 | . | |
| False Positives | 0 | 0% | 0 out of 94 |
| Plotted Points Statistics |
| DIMETHOATE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 51% | 16% | 50% | 15% |
| Total | 69 | 51% | 16% | 50% | 15% |
| Sample Statistics |
| DIMETHOATE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 69 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| DISULFOTON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 68% | 12% | 68% | 13% |
| >= Reporting Level | 62 | 52% | 21% | 57% | 20% |
| Total | 64 | 52% | 21% | 58% | 19% |
| Sample Statistics |
| DISULFOTON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 64 | 90% | Spiked |
| Estimated Values | 64 | 90% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 7 | 10% | 7 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| DISULFOTON SULFONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 57 | 86% | 17% | 85% | 13% |
| Total | 57 | 86% | 17% | 85% | 13% |
| Sample Statistics |
| DISULFOTON SULFONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 57 | 100% | Spiked |
| Estimated Values | 1 | 2% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 57 | . | |
| False Negatives | 0 | 0% | 0 out of 57 |
| Not Spiked | 106 | . | |
| False Positives | 1 | 1% | 1 out of 106 |
| Plotted Points Statistics |
| ENDOSULFAN SULFATE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 67 | 85% | 14% | 86% | 13% |
| Total | 67 | 85% | 14% | 86% | 13% |
| Sample Statistics |
| ENDOSULFAN SULFATE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 67 | 99% | Spiked |
| Estimated Values | 4 | 6% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 1 | 1% | 1 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| EPTC |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 102% | 11% | 101% | 9% |
| Total | 69 | 102% | 11% | 101% | 9% |
| Sample Statistics |
| EPTC |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 4 | 6% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| ETHION |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 86% | 18% | 84% | 17% |
| Total | 68 | 86% | 18% | 84% | 17% |
| Sample Statistics |
| ETHION |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 2 | 2% | 2 out of 100 |
| Plotted Points Statistics |
| ETHION MONOXON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 8 | 93% | 16% | 88% | 21% |
| Total | 8 | 93% | 16% | 88% | 21% |
| Sample Statistics |
| ETHION MONOXON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 8 | 100% | Spiked |
| Estimated Values | 8 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 8 | . | |
| False Negatives | 0 | 0% | 0 out of 8 |
| Not Spiked | 160 | . | |
| False Positives | 5 | 3% | 5 out of 160 |
| Plotted Points Statistics |
| ETHOPROPHOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 65 | 102% | 20% | 101% | 16% |
| Total | 65 | 102% | 20% | 101% | 16% |
| Sample Statistics |
| ETHOPROPHOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 65 | 96% | Spiked |
| Estimated Values | 8 | 12% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 3% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 1 | 1% | 1 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 2 | 2% | 2 out of 100 |
| Plotted Points Statistics |
| FENAMIPHOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 114% | . | 114% | 0% |
| >= Reporting Level | 70 | 79% | 27% | 78% | 22% |
| Total | 71 | 80% | 27% | 78% | 22% |
| Sample Statistics |
| FENAMIPHOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| Plotted Points Statistics |
| FENAMIPHOS SULFONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 120% | 56% | 106% | 61% |
| >= Reporting Level | 67 | 92% | 24% | 88% | 25% |
| Total | 71 | 94% | 27% | 88% | 25% |
| Sample Statistics |
| FENAMIPHOS SULFONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 16 | 23% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| FENAMIPHOS SULFOXIDE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 5 | 43% | 31% | 41% | 18% |
| >= Reporting Level | 59 | 34% | 23% | 26% | 19% |
| Total | 64 | 35% | 24% | 26% | 19% |
| Sample Statistics |
| FENAMIPHOS SULFOXIDE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 64 | 90% | Spiked |
| Estimated Values | 64 | 90% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 6 | 8% | 6 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 3 | 3% | 3 out of 96 |
| Plotted Points Statistics |
| FIPRONIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 73 | 98% | 22% | 98% | 20% |
| Total | 73 | 98% | 22% | 98% | 20% |
| Sample Statistics |
| FIPRONIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 73 | 99% | Spiked |
| Estimated Values | 73 | 99% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 1 | 1% | 1 out of 74 |
| Not Spiked | 94 | . | |
| False Positives | 3 | 3% | 3 out of 94 |
| Plotted Points Statistics |
| FIPRONIL SULFIDE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 65 | 99% | 20% | 97% | 16% |
| Total | 65 | 99% | 20% | 97% | 16% |
| Sample Statistics |
| FIPRONIL SULFIDE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 65 | 98% | Spiked |
| Estimated Values | 1 | 2% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 66 | . | |
| False Negatives | 1 | 2% | 1 out of 66 |
| Not Spiked | 102 | . | |
| False Positives | 22 | 22% | 22 out of 102 |
| Plotted Points Statistics |
| FIPRONIL SULFONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 84% | 24% | 80% | 16% |
| Total | 69 | 84% | 24% | 80% | 16% |
| Sample Statistics |
| FIPRONIL SULFONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 99% | Spiked |
| Estimated Values | 6 | 9% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 1 | 1% | 1 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 3 | 3% | 3 out of 98 |
| Plotted Points Statistics |
| FONOFOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 71 | 89% | 22% | 88% | 16% |
| Total | 71 | 89% | 22% | 88% | 16% |
| Sample Statistics |
| FONOFOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 96% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 3 | 4% | 3 out of 74 |
| Not Spiked | 94 | . | |
| False Positives | 0 | 0% | 0 out of 94 |
| Plotted Points Statistics |
| HEXAZINONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 67% | 19% | 68% | 20% |
| Total | 70 | 67% | 19% | 68% | 20% |
| Sample Statistics |
| HEXAZINONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 99% | Spiked |
| Estimated Values | 6 | 8% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 1 | 1% | 1 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| IPRODIONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 62 | 77% | 21% | 81% | 17% |
| Total | 62 | 77% | 21% | 81% | 17% |
| Sample Statistics |
| IPRODIONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 62 | 89% | Spiked |
| Estimated Values | 62 | 89% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 8 | 11% | 8 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 0 | 0% | 0 out of 98 |
| Plotted Points Statistics |
| ISOFENPHOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 65 | 103% | 23% | 100% | 23% |
| Total | 65 | 103% | 23% | 100% | 23% |
| Sample Statistics |
| ISOFENPHOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 65 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 65 | . | |
| False Negatives | 0 | 0% | 0 out of 65 |
| Not Spiked | 103 | . | |
| False Positives | 0 | 0% | 0 out of 103 |
| Plotted Points Statistics |
| MALAOXON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 94% | 23% | 85% | 33% |
| >= Reporting Level | 68 | 96% | 22% | 95% | 20% |
| Total | 71 | 96% | 22% | 95% | 21% |
| Sample Statistics |
| MALAOXON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 14 | 20% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| Plotted Points Statistics |
| MALATHION |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 92% | 18% | 90% | 16% |
| Total | 68 | 92% | 18% | 90% | 16% |
| Sample Statistics |
| MALATHION |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| METALAXYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 98% | 15% | 97% | 13% |
| Total | 70 | 98% | 15% | 97% | 13% |
| Sample Statistics |
| METALAXYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 99% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 1 | 1% | 1 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| BQS OBSP Determination: |
| METHIDATHION (SUPRACIDE) |
| SCHEDULE: 2033 , TESTIDCODE: 61598GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| METHIDATHION (SUPRACIDE) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 66 | 89% | 17% | 86% | 17% |
| Total | 66 | 89% | 17% | 86% | 17% |
| Sample Statistics |
| METHIDATHION (SUPRACIDE) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 66 | 99% | Spiked |
| Estimated Values | 4 | 6% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 67 | . | |
| False Negatives | 1 | 1% | 1 out of 67 |
| Not Spiked | 101 | . | |
| False Positives | 0 | 0% | 0 out of 101 |
| Plotted Points Statistics |
| METOLACHLOR |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 75 | 93% | 21% | 90% | 14% |
| Total | 75 | 93% | 21% | 90% | 14% |
| Sample Statistics |
| METOLACHLOR |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 75 | 100% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 75 | . | |
| False Negatives | 0 | 0% | 0 out of 75 |
| Not Spiked | 93 | . | |
| False Positives | 0 | 0% | 0 out of 93 |
| Plotted Points Statistics |
| METRIBUZIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 89% | 19% | 89% | 19% |
| Total | 68 | 89% | 19% | 89% | 19% |
| Sample Statistics |
| METRIBUZIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| MOLINATE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 101% | 10% | 100% | 9% |
| Total | 68 | 101% | 10% | 100% | 9% |
| Sample Statistics |
| MOLINATE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 99% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 1 | 1% | 1 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| MYCLOBUTANIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 74 | 77% | 14% | 78% | 13% |
| Total | 74 | 77% | 14% | 78% | 13% |
| Sample Statistics |
| MYCLOBUTANIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 74 | 100% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 0 | 0% | 0 out of 74 |
| Not Spiked | 94 | . | |
| False Positives | 0 | 0% | 0 out of 94 |
| Plotted Points Statistics |
| OXYFLUORFEN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 80% | 19% | 78% | 17% |
| Total | 69 | 80% | 19% | 78% | 17% |
| Sample Statistics |
| OXYFLUORFEN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 4 | 6% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| PARAOXON-METHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 67 | 97% | 25% | 97% | 20% |
| Total | 67 | 97% | 25% | 97% | 20% |
| Sample Statistics |
| PARAOXON-METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 67 | 99% | Spiked |
| Estimated Values | 67 | 99% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 1 | 1% | 1 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| PARATHION-METHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 74 | 102% | 20% | 99% | 19% |
| Total | 74 | 102% | 20% | 99% | 19% |
| Sample Statistics |
| PARATHION-METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 74 | 100% | Spiked |
| Estimated Values | 7 | 9% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 0 | 0% | 0 out of 74 |
| Not Spiked | 94 | . | |
| False Positives | 0 | 0% | 0 out of 94 |
| Plotted Points Statistics |
| PENDIMETHALIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 96% | 21% | 93% | 21% |
| Total | 68 | 96% | 21% | 93% | 21% |
| Sample Statistics |
| PENDIMETHALIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 0 | 0% | 0 out of 100 |
| Plotted Points Statistics |
| PHORATE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 70% | 20% | 72% | 18% |
| Total | 69 | 70% | 20% | 72% | 18% |
| Sample Statistics |
| PHORATE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 97% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 2 | 3% | 2 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| PHORATE OXON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 118% | . | 118% | 0% |
| >= Reporting Level | 45 | 79% | 30% | 76% | 27% |
| Total | 46 | 79% | 30% | 76% | 30% |
| Sample Statistics |
| PHORATE OXON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 46 | 96% | Spiked |
| Estimated Values | 46 | 96% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 48 | . | |
| False Negatives | 2 | 4% | 2 out of 48 |
| Not Spiked | 120 | . | |
| False Positives | 0 | 0% | 0 out of 120 |
| Plotted Points Statistics |
| PHOSMET (IMIDAN) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 12 | 82% | 30% | 77% | 35% |
| >= Reporting Level | 53 | 61% | 23% | 61% | 20% |
| Total | 65 | 65% | 25% | 66% | 20% |
| Sample Statistics |
| PHOSMET (IMIDAN) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 65 | 89% | Spiked |
| Estimated Values | 65 | 89% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 6 | 8% | Spiked |
| Spiked | 73 | . | |
| False Negatives | 2 | 3% | 2 out of 73 |
| Not Spiked | 95 | . | |
| False Positives | 0 | 0% | 0 out of 95 |
| Plotted Points Statistics |
| PHOSMET OXON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 35% | 13% | 34% | 19% |
| >= Reporting Level | 36 | 90% | 69% | 83% | 32% |
| Total | 39 | 86% | 68% | 79% | 36% |
| Sample Statistics |
| PHOSMET OXON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 39 | 83% | Spiked |
| Estimated Values | 39 | 83% | Spiked |
| Deleted Values | 6 | 4% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 48 | . | |
| False Negatives | 7 | 15% | 7 out of 47 |
| Not Spiked | 120 | . | |
| False Positives | 0 | 0% | 0 out of 115 |
| Plotted Points Statistics |
| PROMETON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 90% | 15% | 92% | 14% |
| Total | 70 | 90% | 15% | 92% | 14% |
| Sample Statistics |
| PROMETON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 0 | 0% | 0 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 1 | 1% | 1 out of 98 |
| Plotted Points Statistics |
| PROMETRYN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 65 | 92% | 18% | 90% | 14% |
| Total | 65 | 92% | 18% | 90% | 14% |
| Sample Statistics |
| PROMETRYN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 65 | 100% | Spiked |
| Estimated Values | 3 | 5% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 65 | . | |
| False Negatives | 0 | 0% | 0 out of 65 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| Plotted Points Statistics |
| PROPANIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 109% | 21% | 107% | 18% |
| Total | 70 | 109% | 21% | 107% | 18% |
| Sample Statistics |
| PROPANIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 100% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 0 | 0% | 0 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 0 | 0% | 0 out of 98 |
| Plotted Points Statistics |
| PROPARGITE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 84% | 35% | 76% | 33% |
| Total | 70 | 84% | 35% | 76% | 33% |
| Sample Statistics |
| PROPARGITE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 99% | Spiked |
| Estimated Values | 11 | 15% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| BQS OBSP Determination: |
| PROPYZAMIDE (PRONAMIDE) |
| SCHEDULE: 2033 , TESTIDCODE: 82676GCM35 |
| Open Data Set |
| Plotted Points Statistics |
| PROPYZAMIDE (PRONAMIDE) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 94% | 13% | 93% | 15% |
| Total | 69 | 94% | 13% | 93% | 15% |
| Sample Statistics |
| PROPYZAMIDE (PRONAMIDE) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 0 | 0% | 0 out of 69 |
| Not Spiked | 99 | . | |
| False Positives | 0 | 0% | 0 out of 99 |
| Plotted Points Statistics |
| SIMAZINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 92% | 14% | 93% | 12% |
| Total | 70 | 92% | 14% | 93% | 12% |
| Sample Statistics |
| SIMAZINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 0 | 0% | 0 out of 70 |
| Not Spiked | 98 | . | |
| False Positives | 6 | 6% | 6 out of 98 |
| Plotted Points Statistics |
| TEBUCONAZOLE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 48 | 64% | 15% | 60% | 12% |
| Total | 48 | 64% | 15% | 60% | 12% |
| Sample Statistics |
| TEBUCONAZOLE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 48 | 100% | Spiked |
| Estimated Values | 2 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 48 | . | |
| False Negatives | 0 | 0% | 0 out of 48 |
| Not Spiked | 120 | . | |
| False Positives | 0 | 0% | 0 out of 120 |
| Plotted Points Statistics |
| TEBUTHIURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 211% | . | 211% | 0% |
| >= Reporting Level | 70 | 143% | 37% | 139% | 38% |
| Total | 71 | 144% | 38% | 140% | 38% |
| Sample Statistics |
| TEBUTHIURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 100% | Spiked |
| Estimated Values | 21 | 30% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 0 | 0% | 0 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 0 | 0% | 0 out of 97 |
| Plotted Points Statistics |
| TEFLUTHRIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 66 | 90% | 234% | 62% | 13% |
| Total | 66 | 90% | 234% | 62% | 13% |
| Sample Statistics |
| TEFLUTHRIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 66 | 100% | Spiked |
| Estimated Values | 66 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 66 | . | |
| False Negatives | 0 | 0% | 0 out of 66 |
| Not Spiked | 102 | . | |
| False Positives | 1 | 1% | 1 out of 102 |
| Plotted Points Statistics |
| TERBUFOS |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 62% | 18% | 63% | 15% |
| Total | 68 | 62% | 18% | 63% | 15% |
| Sample Statistics |
| TERBUFOS |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 96% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 3 | 4% | 3 out of 71 |
| Not Spiked | 97 | . | |
| False Positives | 1 | 1% | 1 out of 97 |
| BQS OBSP Determination: |
| TERBUFOS-O-ANALOGUE SULFONE |
| SCHEDULE: 2033 , TESTIDCODE: 61674GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| TERBUFOS-O-ANALOGUE SULFONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 7 | 106% | 19% | 106% | 11% |
| >= Reporting Level | 16 | 71% | 14% | 69% | 21% |
| Total | 23 | 82% | 22% | 80% | 26% |
| Sample Statistics |
| TERBUFOS-O-ANALOGUE SULFONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 23 | 77% | Spiked |
| Estimated Values | 1 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 30 | . | |
| False Negatives | 7 | 23% | 7 out of 30 |
| Not Spiked | 138 | . | |
| False Positives | 0 | 0% | 0 out of 138 |
| Plotted Points Statistics |
| TERBUTHYLAZINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 73 | 101% | 15% | 101% | 12% |
| Total | 73 | 101% | 15% | 101% | 12% |
| Sample Statistics |
| TERBUTHYLAZINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 73 | 100% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 73 | . | |
| False Negatives | 0 | 0% | 0 out of 73 |
| Not Spiked | 95 | . | |
| False Positives | 1 | 1% | 1 out of 95 |
| Plotted Points Statistics |
| THIOBENCARB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 90% | 17% | 92% | 16% |
| Total | 68 | 90% | 17% | 92% | 16% |
| Sample Statistics |
| THIOBENCARB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 100% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 68 |
| Not Spiked | 100 | . | |
| False Positives | 5 | 5% | 5 out of 100 |
| Plotted Points Statistics |
| TRANS-PROPICONAZOLE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 37 | 72% | 16% | 70% | 15% |
| Total | 37 | 72% | 16% | 70% | 15% |
| Sample Statistics |
| TRANS-PROPICONAZOLE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 37 | 100% | Spiked |
| Estimated Values | 37 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 37 | . | |
| False Negatives | 0 | 0% | 0 out of 37 |
| Not Spiked | 131 | . | |
| False Positives | 0 | 0% | 0 out of 131 |
| BQS OBSP Determination: |
| TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
| SCHEDULE: 2033 , TESTIDCODE: 61610GCM39 |
| Open Data Set |
| Plotted Points Statistics |
| TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 66 | 61% | 14% | 59% | 15% |
| Total | 66 | 61% | 14% | 59% | 15% |
| Sample Statistics |
| TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 66 | 100% | Spiked |
| Estimated Values | 66 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 66 | . | |
| False Negatives | 0 | 0% | 0 out of 66 |
| Not Spiked | 102 | . | |
| False Positives | 2 | 2% | 2 out of 102 |